newsfilter
← Latest News
GlobeNewswire·

Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market

Uplisting reflects Palvella's continued progress advancing potential first-in-disease therapies for serious, rare skin diseases and vascular malformations WAYNE, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Palvella